CCP
ELV icon

Corient Capital Partners’s Elevance Health ELV Stock Holding History

Corient Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.02M Buy
4,188
+62
+2% +$29.7K 0.15% 121
2022
Q2 		$1.99M Buy
4,126
+702
+21% +$347K 0.15% 132
2022
Q1 		$1.68M Buy
3,424
+557
+19% +$255K 0.11% 167
2021
Q4 		$1.33M Buy
2,867
+144
+5% +$60.6K 0.09% 200
2021
Q3 		$1.01M Buy
2,723
+117
+4% +$44.5K 0.07% 215
2021
Q2 		$995K Buy
2,606
+289
+12% +$110K 0.07% 214
2021
Q1 		$832K Buy
2,317
+306
+15% +$98.4K 0.07% 221
2020
Q4 		$646K Buy
2,011
+152
+8% +$46.6K 0.06% 238
2020
Q3 		$499K Sell
1,859
-14
-0.7% -$3.77K 0.06% 253
2020
Q2 		$493K Buy
1,873
+30
+2% +$8K 0.06% 250
2020
Q1 		$419K Sell
1,843
-37
-2% -$10.1K 0.07% 244
2019
Q4 		$568K Buy
1,880
+510
+37% +$140K 0.07% 262
2019
Q3 		$329K Sell
1,370
-347
-20% -$95.1K 0.05% 334
2019
Q2 		$485K Buy
1,717
+280
+19% +$76.5K 0.07% 242
2019
Q1 		$412K Buy
1,437
+550
+62% +$159K 0.07% 249
2018
Q4 		$233K Buy
+887
New +$244K 0.04% 284
2018
Q1 		– Sell
-12,803
Closed -$2.88M – 262
2017
Q4 		$2.88M Sell
12,803
-141
-1% -$30K 0.49% 60
2017
Q3 		$2.46M Sell
12,944
-1,756
-12% -$334K 0.46% 59
2017
Q2 		$2.77M Sell
14,700
-1,550
-10% -$279K 0.42% 58
2017
Q1 		$2.69M Buy
16,250
+584
+4% +$92.9K 0.42% 61
2016
Q4 		$2.25M Buy
15,666
+842
+6% +$113K 0.4% 66
2016
Q3 		$1.86M Buy
+14,824
New +$1.91M 0.34% 76

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Corient Capital Partners's ELV Position: Q3 2022 in Review

Corient Capital Partners increased its Elevance Health (ELV) stake by 1.5% in Q3 2022, buying an estimated $29.7K and bringing the position to 4,188 shares worth $2.02M. The position accounts for 0.15% of the portfolio, ranked #121.

Corient Capital Partners first reported a position in ELV in Q3 2016 and has held it in 22 quarters since. The position peaked at $2.88M in Q4 2017. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Corient Capital Partners held 4,188 shares of Elevance Health worth $2.02M as of Q3 2022.
  • Corient Capital Partners bought 62 Elevance Health shares in Q3 2022, an estimated $29.7K.
  • Elevance Health made up 0.15% of Corient Capital Partners's portfolio in Q3 2022, its #121 holding.
  • Corient Capital Partners first reported a position in Elevance Health in Q3 2016 and has held it in 22 quarters since.
  • Corient Capital Partners's Elevance Health position peaked at $2.88M in Q4 2017.
  • 1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.